Background We have previously estimated that respiratory syncytial virus (RSV) was
associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) …

Background Respiratory viruses are the leading cause of lower respiratory tract infection
(LRTI) and hospitalisation in infants and young children. Respiratory syncytial virus (RSV) is …

With progressive digitalization of healthcare systems worldwide, large-scale collection of
electronic health records (EHRs) has become commonplace. However, an extensible …

Background Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory
infection (ALRI) in young children aged< 5 years. Methods We aimed to identify the global …

Background Respiratory syncytial virus (RSV) frequently causes acute lower respiratory
infection in children under 5, representing a high burden in Gavi-eligible countries (mostly …

Background Introduction of pneumococcal conjugate vaccines (PCVs) has substantially
reduced disease burden due to Streptococcus pneumoniae, a leading cause of childhood …

Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …

Abstract Background The World Health Organization (WHO) recommends oral amoxicillin for
patients who have pneumonia with tachypnea, yet trial data indicate that not using …

Objectives Interventions to prevent childhood respiratory syncytial virus (RSV) disease are
limited and costly. New interventions are in advanced stages of development and could be …

Pneumonia remains the leading cause of death globally in children under the age of five.
The poorest children are the ones most at risk of dying. In the recent years, lung ultrasound …